Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.22
+0.17 (2.81%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Puma Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 29.64 | 69.22 | 84.59 | 76.2 | 63.13 | Upgrade
|
| Short-Term Investments | 67.89 | 31.75 | 11.35 | 4.87 | 18.98 | Upgrade
|
| Cash & Short-Term Investments | 97.53 | 100.97 | 95.94 | 81.07 | 82.11 | Upgrade
|
| Cash Growth | -3.40% | 5.24% | 18.34% | -1.26% | -12.08% | Upgrade
|
| Accounts Receivable | 53.65 | 32.01 | 47.84 | 40.35 | 32.53 | Upgrade
|
| Other Receivables | - | - | - | 1.92 | - | Upgrade
|
| Receivables | 53.65 | 32.01 | 47.84 | 42.27 | 32.53 | Upgrade
|
| Inventory | 5.52 | 8.72 | 7.08 | 4.53 | 7.11 | Upgrade
|
| Prepaid Expenses | 1.63 | 1.83 | 2.48 | 2.62 | 8.98 | Upgrade
|
| Restricted Cash | 2.09 | - | - | - | 8.85 | Upgrade
|
| Other Current Assets | 2.27 | 4.13 | 2.85 | 3.79 | 0.45 | Upgrade
|
| Total Current Assets | 162.69 | 147.66 | 156.19 | 134.28 | 140.02 | Upgrade
|
| Property, Plant & Equipment | 5.56 | 5.09 | 8.65 | 12.51 | 15.77 | Upgrade
|
| Other Intangible Assets | 41.39 | 51.13 | 60.87 | 70.61 | 66.13 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.83 | 7.08 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | 0.1 | 0.1 | 0.21 | - | 0.58 | Upgrade
|
| Other Long-Term Assets | 2.73 | 2.27 | 4.62 | 4.66 | 4.09 | Upgrade
|
| Total Assets | 216.3 | 213.33 | 230.53 | 222.06 | 226.59 | Upgrade
|
| Accounts Payable | 5.06 | 5.51 | 6.89 | 6.44 | 11.17 | Upgrade
|
| Accrued Expenses | 35.82 | 26.07 | 35.63 | 32.73 | 24.03 | Upgrade
|
| Current Portion of Long-Term Debt | 22.52 | 45.33 | 34 | - | - | Upgrade
|
| Current Portion of Leases | 1.31 | 5.54 | 4.8 | 4.14 | 3.57 | Upgrade
|
| Other Current Liabilities | 16.54 | 13.66 | 18.07 | 34.17 | 70.81 | Upgrade
|
| Total Current Liabilities | 81.25 | 96.11 | 99.38 | 77.48 | 109.59 | Upgrade
|
| Long-Term Debt | - | 21.72 | 65.66 | 98.31 | 97.09 | Upgrade
|
| Long-Term Leases | 4.71 | 1.49 | 7.03 | 11.83 | 15.98 | Upgrade
|
| Other Long-Term Liabilities | - | 1.88 | 5.01 | 12.83 | 6.38 | Upgrade
|
| Total Liabilities | 85.96 | 121.21 | 177.09 | 200.45 | 229.03 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,414 | 1,407 | 1,399 | 1,388 | 1,364 | Upgrade
|
| Retained Earnings | -1,284 | -1,315 | -1,345 | -1,367 | -1,367 | Upgrade
|
| Comprehensive Income & Other | 0.04 | 0.01 | -0 | - | -0 | Upgrade
|
| Shareholders' Equity | 130.34 | 92.13 | 53.44 | 21.61 | -2.45 | Upgrade
|
| Total Liabilities & Equity | 216.3 | 213.33 | 230.53 | 222.06 | 226.59 | Upgrade
|
| Total Debt | 28.55 | 74.08 | 111.49 | 114.28 | 116.64 | Upgrade
|
| Net Cash (Debt) | 68.98 | 26.88 | -15.55 | -33.21 | -34.54 | Upgrade
|
| Net Cash Growth | 156.60% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 1.36 | 0.55 | -0.33 | -0.74 | -0.85 | Upgrade
|
| Filing Date Shares Outstanding | 50.88 | 49.61 | 48.21 | 46.64 | 41.33 | Upgrade
|
| Total Common Shares Outstanding | 50.41 | 49.11 | 47.65 | 46.35 | 41.18 | Upgrade
|
| Working Capital | 81.43 | 51.55 | 56.8 | 56.8 | 30.44 | Upgrade
|
| Book Value Per Share | 2.59 | 1.88 | 1.12 | 0.47 | -0.06 | Upgrade
|
| Tangible Book Value | 88.95 | 40.99 | -7.43 | -49 | -68.57 | Upgrade
|
| Tangible Book Value Per Share | 1.76 | 0.83 | -0.16 | -1.06 | -1.67 | Upgrade
|
| Machinery | 2.24 | 4.6 | 4.76 | 4.79 | 4.84 | Upgrade
|
| Leasehold Improvements | 2.55 | 3.78 | 3.78 | 3.78 | 3.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.